Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by Korean South West Oncology Group.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Korean South West Oncology Group Identifier:
First received: December 14, 2011
Last updated: December 19, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)